Inventor · disambiguated record
Darrell R. Anderson
Also filed as: ANDERSON DARRELL R
22 granted patents·4 pending applications·3,469 citations·filing 1993–2008
97Inventor score
Top patents by PatentIndex Score
26 records- 0199US7422739B2Anti-CD20 antibodiesBIOGEN IDEC INC·Filed 2001·Granted Sep 9, 2008·166 cites·13 claims
- 0299US5736137ATherapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphomaIDEC PHARMA CORP·Filed 1993·Granted Apr 7, 1998·1.6k cites·6 claims
- 0398US6399061B1Chimeric and radiolabelled antibodies specific to human CD20 antigen and use thereof for treatment of B-cell lymphomaIDEC PHARMA CORP·Filed 1995·Granted Jun 4, 2002·254 cites·7 claims
- 0498US5843439ATherapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphomaFiled 1995·Granted Dec 1, 1998·336 cites·7 claims
- 0598US5776456ATherapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphomaIDEC PHARMA CORP·Filed 1995·Granted Jul 7, 1998·527 cites·14 claims
- 0697US6682734B1Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphomaIDEC PHARMA CORP·Filed 1995·Granted Jan 27, 2004·176 cites·13 claims
- 0797US6113898AHuman B7.1-specific primatized antibodies and transfectomas expressing said antibodiesIDEC PHARMA CORP·Filed 1995·Granted Sep 5, 2000·207 cites·11 claims
- 0896US7381560B2Expression and use of anti-CD20 antibodiesBIOGEN IDEC INC·Filed 2001·Granted Jun 3, 2008·45 cites·10 claims
- 0995US7192585B2CD80 specific antibodiesBIOGEN IDEC INC·Filed 2005·Granted Mar 20, 2007·17 cites·20 claims
- 1093US7744877B2Expression and use of anti-CD20 AntibodiesBIOGEN IDEC INC·Filed 2002·Granted Jun 29, 2010·38 cites·8 claims
- 1192US6893638B2Methods for treating b cell lymphoma using CD80-specific antibodiesFiled 2001·Granted May 17, 2005·40 cites·5 claims
- 1291US7491393B2Methods of inhibiting IL-2 production by T cells by administering 7C10 and 16C10 CD80-specific antibodiesBIOGEN IDEC INC·Filed 2007·Granted Feb 17, 2009·4 cites·20 claims
- 1391US7175847B1Treating intestinal inflammation with anti-CD80 antibodies that do not inhibit CD80 binding to CTLA-4BIOGEN IDEC INC·Filed 2000·Granted Feb 13, 2007·13 cites·45 claims
- 1490US7153508B2Treatment of B cell lymphoma using anti-CD80 antibodies that do not inhibit the binding of CD80 to CTLA-4BIOGEN IDEC INC·Filed 2002·Granted Dec 26, 2006·19 cites·26 claims
- 1588US7510712B2Methods of treating rheumatoid arthritis with 7C10 and 16C10 CD80-specific antibodiesBIOGEN IDEC INC·Filed 2007·Granted Mar 31, 2009·5 cites·20 claims
- 1687US7425447B2Host cells expressing 7C10 and 16C10 CD80-specific antibodiesBIOGEN IDEC INC·Filed 2006·Granted Sep 16, 2008·5 cites·44 claims
- 1786US7417128B27C10 and 16C10 CD80-specific antibodiesBIOGEN IDEC INC·Filed 2006·Granted Aug 26, 2008·5 cites·13 claims
- 1881US7510713B2Methods of inducing immunosuppression by administering 7C10 and 16C10 CD80-specific antibodiesBIOGEN IDEC INC·Filed 2007·Granted Mar 31, 2009·1 cites·20 claims
- 1980US7414123B2Nucleic acids encoding 7C10 and 16C10 CD80-specific antibodiesBIOGEN IDEC INC·Filed 2006·Granted Aug 19, 2008·1 cites·16 claims
- 2078US7501264B2Methods of producing 7C10 and 16C10 CD80-specific antibodiesBIOGEN IDEC INC·Filed 2007·Granted Mar 10, 2009·1 cites·23 claims
- 2176US6709654B1Treatment of psoriasis using anti-B7.1 (CD80) antibodiesFiled 1999·Granted Mar 23, 2004·28 cites·7 claims
- 2273US7323170B2Anti-CD80 antibodiesBIOGEN IDEC INC·Filed 2004·Granted Jan 29, 2008·4 cites·30 claims
- 2371US2009124791A1Identification of unique binding interactions between certain antibodies and the human b7.1 and b7.2 co-stimulatory antigensBIOGEN IDEC INC·Filed 2008·Application pending·0 cites
- 2460US2005186205A1Therapeutic application of chimeric and radiolabeled antibodies to human B Lymphocyte restricted differentiation antigen for treatment of B cell LymphomaFiled 2004·Application pending·0 cites
- 2560US2003021781A1Therapeutic application of chimeric and radiolabelled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphomaIDEC PHARMA CORP·Filed 2001·Application pending·0 cites
- 2648US2003082172A1Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphomaIDEC PHARMACEUTICALS·Filed 2002·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →